Lung inflammation

September 14, 2020
Lungs

Now Enrolling: EAQ172 for Treatment of Lung Inflammation in Patients with Any Type of Cancer

This phase II trial by EA's Cancer Control and Survivorship Committee is comparing two promising pneumonitis treatments for patients receiving PD-1/PD-L1 therapy